NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

核酸檢驗 (NAT)的全球市場

Nucleic Acid Testing

出版商 Global Industry Analysts, Inc. 商品編碼 912682
出版日期 內容資訊 英文 283 Pages
商品交期: 最快1-2個工作天內
價格
核酸檢驗 (NAT)的全球市場 Nucleic Acid Testing
出版日期: 2021年04月01日內容資訊: 英文 283 Pages
簡介

本報告提供全球核酸檢驗 (NAT) 市場相關調查分析,提供市場概要,主要企業,市場趨勢·促進因素,全球市場預測,各地區市場分析,競爭情形相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球競爭企業的市場佔有率
  • 主要企業
  • 市場趨勢·促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他的歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他的亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • UAE
    • 其他中東
    • 非洲

第4章 競爭

  • ABBOTT MOLECULAR
  • BECKMAN COULTER - LIFE SCIENCE DIVISION
  • BECTON, DICKINSON AND COMPANY
  • BIO-RAD LABORATORIES, INC.
  • F. HOFFMANN-LA ROCHE AG
  • ILLUMINA
  • NOVARTIS INTERNATIONAL AG
  • SEQUENOM
  • SIEMENS HEALTHINEERS
  • TECAN GROUP

第5章 相關調查

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6070

Abstract:

Global Nucleic Acid Testing Market to Reach $4.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Nucleic Acid Testing estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$4.1 Billion by 2027, growing at aCAGR of 6.3% over the period 2020-2027. Nucleic Acid Test Kits, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $721.5 Million, While China is Forecast to Grow at 9.6% CAGR

The Nucleic Acid Testing market in the U.S. is estimated at US$721.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$877.1 Million by the year 2027 trailing a CAGR of 9.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular, Inc.
  • Beckman Coulter - Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Nucleic Acid Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 22: USA Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 34: Japan Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Japan Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Japan 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 46: Europe Current & Future Analysis for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: France 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 58: France Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Germany 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 64: Germany Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Italy 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 70: Italy Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: UK 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 76: UK Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 79: Spain Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Spain Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Spain 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 82: Spain Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Spain Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Spain 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 85: Russia Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Russia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Russia 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 88: Russia Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Russia Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Russia 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 91: Rest of Europe Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of Europe 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 94: Rest of Europe Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of Europe Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of Europe 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 97: Asia-Pacific Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 98: Asia-Pacific Historic Review for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 100: Asia-Pacific Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 106: Australia Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Australia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Australia 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 109: Australia Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Australia Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Australia 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 112: India Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: India Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: India 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 115: India Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: India Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: India 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 118: South Korea Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: South Korea Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: South Korea 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 121: South Korea Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: South Korea Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: South Korea 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Rest of Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: Rest of Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Rest of Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 130: Latin America Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 131: Latin America Historic Review for Nucleic Acid Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Latin America 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 133: Latin America Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Latin America Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Latin America 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 139: Argentina Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Argentina Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: Argentina 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 142: Argentina Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Argentina Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Argentina 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 145: Brazil Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Brazil Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: Brazil 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 148: Brazil Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Brazil Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: Brazil 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 151: Mexico Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Mexico Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: Mexico 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 154: Mexico Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Mexico Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: Mexico 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 157: Rest of Latin America Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Rest of Latin America Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Rest of Latin America 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 160: Rest of Latin America Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Latin America Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Latin America 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 163: Middle East Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 164: Middle East Historic Review for Nucleic Acid Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Middle East 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 166: Middle East Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Middle East Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Middle East 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 172: Iran Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Iran Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Iran 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 175: Iran Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Iran Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Iran 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 178: Israel Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Israel Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Israel 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 181: Israel Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Israel Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Israel 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 184: Saudi Arabia Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Saudi Arabia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Saudi Arabia 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 187: Saudi Arabia Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Saudi Arabia Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Saudi Arabia 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 190: UAE Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: UAE Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: UAE 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 193: UAE Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 194: UAE Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 195: UAE 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 196: Rest of Middle East Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Rest of Middle East Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 198: Rest of Middle East 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 199: Rest of Middle East Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Rest of Middle East Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 201: Rest of Middle East 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 202: Africa Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Africa Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 204: Africa 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2012, 2020 & 2027
    • TABLE 205: Africa Current & Future Analysis for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Africa Historic Review for Nucleic Acid Testing by End-Use - Hospitals, Pathology Laboratories, Research Institutes and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 207: Africa 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pathology Laboratories, Research Institutes and Clinics for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46